New discoveries on ancient loops in DNA offer clues into gene regulation
A heavy skew toward white people makes precision medicine imprecise
Nanoscale devices convert near-infrared light into visible, green light. When injected into the eyes, they enabled mice to see in the infrared
Engineered microorganisms churn out THC, CBD and rarer, less-understood cannabis cousins
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
Nick Sireau’s quest to give his sons weed killer could help thousands struggling with rare genetic conditions
A tortoise and a puffer fish inspire technology to overcome the multibillion-dollar nonadherence problem
Anxiety disorders, addiction, acute pain and stroke rehabilitation are just a few of the areas where VR therapy is already in use
The assays don't always yield results, but the information they offer can, at times, alter the course of treatment or prevention
Biologists have demonstrated for the first time that a controversial genetic engineering technology works, with caveats, in mammals
Promoters hope efforts will also offer insights into treatments used for humans
Evidence continues to mount about the link between postoperative opioid prescriptions and addiction. A new approach could help curb the crisis.
From bionic eyes to gene editing, how can we use science to bring back sight?
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products...
The medical regulatory authorities ride a wave of clinical studies for gene therapies.
The research is promising, but a true cure for this painful condition could be years away.
Insertion of genetic information can prompt the body to make antibody-based drugs, offering a fresh approach to treating diseases such as influenza, as well as infections like HIV.
The hope of gene therapy could be crushed by its financial burden unless there are more rational ways of paying for it, says Michael Sherman.
Gene therapy could one day be used for bodily enhancement, creating an ethical minefield for physicians, says Ellen Wright Clayton.
Gene therapy for single-gene disorders is at a pivotal period in its evolution, with continued successful development requiring tight collaboration among industry, academic, regulatory, clinical and patient communities...